No Data
J.P. Morgan Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Cuts Target Price to $45
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
Express News | Amphastar Pharmaceuticals Inc : JP Morgan Cuts Target Price to $45 From $60
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors
This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Maintains Target Price $36
Shifting Gears : all the good shares on his side
Simon 5183 : The lower Trump's stock price, the greater the pressure from Financial Street, which means that Trump's chances of winning are greater.
dookiro : Will interest fed rate drop drastically if Trump were to win?
D3VIN-007 dookiro : no
Mr Neitaniel :
View more comments...